HEADER FLUORESCENT PROTEIN 03-MAR-08 3CFF TITLE PHOTOSWITCHABLE RED FLUORESCENT PROTEIN PSRFP, ON-STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GFP-LIKE PHOTOSWITCHABLE FLUORESCENT PROTEIN; COMPND 3 CHAIN: L, M, R, S; COMPND 4 SYNONYM: PSRFP; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: GFP-LIKE PHOTOSWITCHABLE FLUORESCENT PROTEIN; COMPND 8 CHAIN: A, B, G, H; COMPND 9 SYNONYM: PSRFP; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ANEMONIA SULCATA; SOURCE 3 ORGANISM_COMMON: MEDITERRANEAN SNAKELOCKS SEA ANEMONE; SOURCE 4 ORGANISM_TAXID: 6108; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET17B; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: ANEMONIA SULCATA; SOURCE 12 ORGANISM_COMMON: MEDITERRANEAN SNAKELOCKS SEA ANEMONE; SOURCE 13 ORGANISM_TAXID: 6108; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET17B KEYWDS BETA BARREL, BETA CAN, CHROMOPHORE, PHOTOACTIVATION, FLUORESCENT KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.S.KACHALOVA,S.GUNDEL,H.D.BARTUNIK,J.WIEDENMANN REVDAT 5 15-NOV-23 3CFF 1 REMARK REVDAT 4 01-NOV-23 3CFF 1 REMARK REVDAT 3 10-NOV-21 3CFF 1 SEQADV LINK REVDAT 2 24-MAR-09 3CFF 1 LINK REVDAT 1 10-MAR-09 3CFF 0 JRNL AUTH S.GUNDEL,G.S.KACHALOVA,F.OSWALD,J.FUCHS,H.D.BARTUNIK, JRNL AUTH 2 G.U.NIENHAUS,J.WIEDENMANN JRNL TITL STRUCTURE OF ANEMONIA SULCATA RED FLUORESCENT PROTEIN ASRFP JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 12.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 100059 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5260 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7091 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.54 REMARK 3 BIN R VALUE (WORKING SET) : 0.2960 REMARK 3 BIN FREE R VALUE SET COUNT : 381 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7148 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 917 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.15000 REMARK 3 B22 (A**2) : 1.47000 REMARK 3 B33 (A**2) : -2.62000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.129 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.120 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.088 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.860 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7784 ; 0.006 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10576 ; 1.095 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 996 ; 6.038 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 357 ;33.077 ;24.202 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1325 ;14.374 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;16.396 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1067 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6097 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3833 ; 0.195 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 5100 ; 0.299 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 1051 ; 0.157 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 86 ; 0.164 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 46 ; 0.198 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4832 ; 0.527 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7583 ; 0.892 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3421 ; 1.078 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2947 ; 1.673 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CFF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000046709. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.05 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 102342 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.58000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3CFA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M DI-SODIUM TARTATE, 40%(W/V) MPD, REMARK 280 PH 7.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 121.31300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 121.31300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 49.20900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.18000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 49.20900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.18000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 121.31300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 49.20900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 49.18000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 121.31300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 49.20900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 49.18000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS PROTEIN CONSISTS OF 4 PROTEIN CHAINS (1-231) AND REMARK 300 INSIDE EACH OF THEM THERE IS BREAK BETWEEN 62 AND 66 AS REMARK 300 CHROMOPHORE. THE BIOLOGICAL UNIT IS TETRAMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 30610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -140.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, A, M, B, R, G, S, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 321 LIES ON A SPECIAL POSITION. REMARK 375 HOH S 92 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET L 1 REMARK 465 ALA L 2 REMARK 465 SER L 3 REMARK 465 LEU L 4 REMARK 465 MET M 1 REMARK 465 ALA M 2 REMARK 465 SER M 3 REMARK 465 LEU M 4 REMARK 465 MET R 1 REMARK 465 ALA R 2 REMARK 465 SER R 3 REMARK 465 LEU R 4 REMARK 465 MET S 1 REMARK 465 ALA S 2 REMARK 465 SER S 3 REMARK 465 LEU S 4 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU G 195 O HOH G 360 1.83 REMARK 500 O HOH A 398 O HOH R 68 1.96 REMARK 500 O HOH G 290 O HOH G 400 2.05 REMARK 500 OE1 GLU B 195 O HOH B 380 2.09 REMARK 500 O HOH G 274 O HOH G 405 2.10 REMARK 500 O HOH A 254 O HOH G 382 2.12 REMARK 500 OD1 ASN L 33 O HOH L 102 2.12 REMARK 500 OD1 ASN R 33 O HOH R 107 2.13 REMARK 500 O CYS R 62 N1 NRQ G 65 2.14 REMARK 500 O HOH G 262 O HOH G 279 2.16 REMARK 500 O CYS L 62 N1 NRQ A 65 2.17 REMARK 500 OH TYR G 213 O HOH G 372 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS M 62 C CYS M 62 OXT 0.158 REMARK 500 CYS R 62 C CYS R 62 OXT 0.116 REMARK 500 CYS S 62 C CYS S 62 OXT 0.175 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 208 -40.87 -131.09 REMARK 500 LYS B 206 105.68 -47.37 REMARK 500 LYS B 208 -51.14 -130.40 REMARK 500 LYS H 206 110.06 -39.46 REMARK 500 LYS H 208 -47.66 -136.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CFA RELATED DB: PDB REMARK 900 ANEMONIA SULCATA FLUORESCENT PROTEIN ASFP595 REMARK 900 RELATED ID: 3CFH RELATED DB: PDB REMARK 900 PHOTOSWITCHABLE RED FLUORESCENT PROTEIN PSRFP, OFF-STATE REMARK 900 RELATED ID: 2A50 RELATED DB: PDB REMARK 900 FLUORESCENT PROTEIN ASFP595, WT, OFF-STATE REMARK 900 RELATED ID: 1XQM RELATED DB: PDB REMARK 900 KINDLING FLUORESCENT PROTEIN REMARK 900 RELATED ID: 1XMZ RELATED DB: PDB REMARK 900 GFP-LIKE CHROMOPROTEIN FP595 DBREF 3CFF L 1 62 PDB 3CFF 3CFF 1 62 DBREF 3CFF A 65 231 PDB 3CFF 3CFF 65 231 DBREF 3CFF M 1 62 PDB 3CFF 3CFF 1 62 DBREF 3CFF B 65 231 PDB 3CFF 3CFF 65 231 DBREF 3CFF R 1 62 PDB 3CFF 3CFF 1 62 DBREF 3CFF G 65 231 PDB 3CFF 3CFF 65 231 DBREF 3CFF S 1 62 PDB 3CFF 3CFF 1 62 DBREF 3CFF H 65 231 PDB 3CFF 3CFF 65 231 SEQADV 3CFF GLY A 143 PDB 3CFF SER 143 ENGINEERED MUTATION SEQADV 3CFF GLY B 143 PDB 3CFF SER 143 ENGINEERED MUTATION SEQADV 3CFF GLY G 143 PDB 3CFF SER 143 ENGINEERED MUTATION SEQADV 3CFF GLY H 143 PDB 3CFF SER 143 ENGINEERED MUTATION SEQRES 1 L 62 MET ALA SER LEU LEU THR GLU THR MET PRO PHE ARG MET SEQRES 2 L 62 THR MET GLU GLY THR VAL ASN GLY HIS HIS PHE LYS CYS SEQRES 3 L 62 THR GLY LYS GLY GLU GLY ASN PRO PHE GLU GLY THR GLN SEQRES 4 L 62 ASP MET LYS ILE GLU VAL ILE GLU GLY GLY PRO LEU PRO SEQRES 5 L 62 PHE ALA PHE ASP ILE LEU SER THR SER CYS SEQRES 1 A 167 NRQ SER LYS THR PHE ILE LYS TYR VAL SER GLY ILE PRO SEQRES 2 A 167 ASP TYR PHE LYS GLN SER PHE PRO GLU GLY PHE THR TRP SEQRES 3 A 167 GLU ARG THR THR THR TYR GLU ASP GLY GLY PHE LEU THR SEQRES 4 A 167 ALA HIS GLN ASP THR SER LEU ASP GLY ASP CME LEU VAL SEQRES 5 A 167 TYR LYS VAL LYS ILE LEU GLY ASN ASN PHE PRO ALA ASP SEQRES 6 A 167 GLY PRO VAL MET GLN ASN LYS ALA GLY GLY TRP GLU PRO SEQRES 7 A 167 GLY CYS GLU ILE LEU TYR GLU VAL ASP GLY VAL LEU CYS SEQRES 8 A 167 GLY GLN SER LEU MET ALA LEU LYS CYS PRO GLY GLY ARG SEQRES 9 A 167 HIS LEU ASN CYS ARG LEU HIS THR THR TYR ARG SER LYS SEQRES 10 A 167 LYS PRO ALA SER ALA LEU LYS MET PRO GLU PHE HIS PHE SEQRES 11 A 167 GLU ASP HIS ARG ILE GLU VAL LYS GLU VAL GLN LYS GLY SEQRES 12 A 167 LYS HIS TYR GLU GLN TYR GLU ALA ALA VAL ALA ARG TYR SEQRES 13 A 167 CME ASP ALA ALA PRO SER LYS LEU GLY HIS HIS SEQRES 1 M 62 MET ALA SER LEU LEU THR GLU THR MET PRO PHE ARG MET SEQRES 2 M 62 THR MET GLU GLY THR VAL ASN GLY HIS HIS PHE LYS CYS SEQRES 3 M 62 THR GLY LYS GLY GLU GLY ASN PRO PHE GLU GLY THR GLN SEQRES 4 M 62 ASP MET LYS ILE GLU VAL ILE GLU GLY GLY PRO LEU PRO SEQRES 5 M 62 PHE ALA PHE ASP ILE LEU SER THR SER CYS SEQRES 1 B 167 NRQ SER LYS THR PHE ILE LYS TYR VAL SER GLY ILE PRO SEQRES 2 B 167 ASP TYR PHE LYS GLN SER PHE PRO GLU GLY PHE THR TRP SEQRES 3 B 167 GLU ARG THR THR THR TYR GLU ASP GLY GLY PHE LEU THR SEQRES 4 B 167 ALA HIS GLN ASP THR SER LEU ASP GLY ASP CME LEU VAL SEQRES 5 B 167 TYR LYS VAL LYS ILE LEU GLY ASN ASN PHE PRO ALA ASP SEQRES 6 B 167 GLY PRO VAL MET GLN ASN LYS ALA GLY GLY TRP GLU PRO SEQRES 7 B 167 GLY CYS GLU ILE LEU TYR GLU VAL ASP GLY VAL LEU CYS SEQRES 8 B 167 GLY GLN SER LEU MET ALA LEU LYS CYS PRO GLY GLY ARG SEQRES 9 B 167 HIS LEU ASN CYS ARG LEU HIS THR THR TYR ARG SER LYS SEQRES 10 B 167 LYS PRO ALA SER ALA LEU LYS MET PRO GLU PHE HIS PHE SEQRES 11 B 167 GLU ASP HIS ARG ILE GLU VAL LYS GLU VAL GLN LYS GLY SEQRES 12 B 167 LYS HIS TYR GLU GLN TYR GLU ALA ALA VAL ALA ARG TYR SEQRES 13 B 167 CME ASP ALA ALA PRO SER LYS LEU GLY HIS HIS SEQRES 1 R 62 MET ALA SER LEU LEU THR GLU THR MET PRO PHE ARG MET SEQRES 2 R 62 THR MET GLU GLY THR VAL ASN GLY HIS HIS PHE LYS CYS SEQRES 3 R 62 THR GLY LYS GLY GLU GLY ASN PRO PHE GLU GLY THR GLN SEQRES 4 R 62 ASP MET LYS ILE GLU VAL ILE GLU GLY GLY PRO LEU PRO SEQRES 5 R 62 PHE ALA PHE ASP ILE LEU SER THR SER CYS SEQRES 1 G 167 NRQ SER LYS THR PHE ILE LYS TYR VAL SER GLY ILE PRO SEQRES 2 G 167 ASP TYR PHE LYS GLN SER PHE PRO GLU GLY PHE THR TRP SEQRES 3 G 167 GLU ARG THR THR THR TYR GLU ASP GLY GLY PHE LEU THR SEQRES 4 G 167 ALA HIS GLN ASP THR SER LEU ASP GLY ASP CME LEU VAL SEQRES 5 G 167 TYR LYS VAL LYS ILE LEU GLY ASN ASN PHE PRO ALA ASP SEQRES 6 G 167 GLY PRO VAL MET GLN ASN LYS ALA GLY GLY TRP GLU PRO SEQRES 7 G 167 GLY CYS GLU ILE LEU TYR GLU VAL ASP GLY VAL LEU CYS SEQRES 8 G 167 GLY GLN SER LEU MET ALA LEU LYS CYS PRO GLY GLY ARG SEQRES 9 G 167 HIS LEU ASN CYS ARG LEU HIS THR THR TYR ARG SER LYS SEQRES 10 G 167 LYS PRO ALA SER ALA LEU LYS MET PRO GLU PHE HIS PHE SEQRES 11 G 167 GLU ASP HIS ARG ILE GLU VAL LYS GLU VAL GLN LYS GLY SEQRES 12 G 167 LYS HIS TYR GLU GLN TYR GLU ALA ALA VAL ALA ARG TYR SEQRES 13 G 167 CME ASP ALA ALA PRO SER LYS LEU GLY HIS HIS SEQRES 1 S 62 MET ALA SER LEU LEU THR GLU THR MET PRO PHE ARG MET SEQRES 2 S 62 THR MET GLU GLY THR VAL ASN GLY HIS HIS PHE LYS CYS SEQRES 3 S 62 THR GLY LYS GLY GLU GLY ASN PRO PHE GLU GLY THR GLN SEQRES 4 S 62 ASP MET LYS ILE GLU VAL ILE GLU GLY GLY PRO LEU PRO SEQRES 5 S 62 PHE ALA PHE ASP ILE LEU SER THR SER CYS SEQRES 1 H 167 NRQ SER LYS THR PHE ILE LYS TYR VAL SER GLY ILE PRO SEQRES 2 H 167 ASP TYR PHE LYS GLN SER PHE PRO GLU GLY PHE THR TRP SEQRES 3 H 167 GLU ARG THR THR THR TYR GLU ASP GLY GLY PHE LEU THR SEQRES 4 H 167 ALA HIS GLN ASP THR SER LEU ASP GLY ASP CME LEU VAL SEQRES 5 H 167 TYR LYS VAL LYS ILE LEU GLY ASN ASN PHE PRO ALA ASP SEQRES 6 H 167 GLY PRO VAL MET GLN ASN LYS ALA GLY GLY TRP GLU PRO SEQRES 7 H 167 GLY CYS GLU ILE LEU TYR GLU VAL ASP GLY VAL LEU CYS SEQRES 8 H 167 GLY GLN SER LEU MET ALA LEU LYS CYS PRO GLY GLY ARG SEQRES 9 H 167 HIS LEU ASN CYS ARG LEU HIS THR THR TYR ARG SER LYS SEQRES 10 H 167 LYS PRO ALA SER ALA LEU LYS MET PRO GLU PHE HIS PHE SEQRES 11 H 167 GLU ASP HIS ARG ILE GLU VAL LYS GLU VAL GLN LYS GLY SEQRES 12 H 167 LYS HIS TYR GLU GLN TYR GLU ALA ALA VAL ALA ARG TYR SEQRES 13 H 167 CME ASP ALA ALA PRO SER LYS LEU GLY HIS HIS MODRES 3CFF NRQ A 65 MET MODRES 3CFF NRQ A 65 TYR MODRES 3CFF NRQ A 65 GLY MODRES 3CFF CME A 114 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3CFF CME A 221 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3CFF NRQ B 65 MET MODRES 3CFF NRQ B 65 TYR MODRES 3CFF NRQ B 65 GLY MODRES 3CFF CME B 114 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3CFF CME B 221 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3CFF NRQ G 65 MET MODRES 3CFF NRQ G 65 TYR MODRES 3CFF NRQ G 65 GLY MODRES 3CFF CME G 114 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3CFF CME G 221 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3CFF NRQ H 65 MET MODRES 3CFF NRQ H 65 TYR MODRES 3CFF NRQ H 65 GLY MODRES 3CFF CME H 114 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3CFF CME H 221 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET NRQ A 65 23 HET CME A 114 10 HET CME A 221 10 HET NRQ B 65 23 HET CME B 114 10 HET CME B 221 10 HET NRQ G 65 23 HET CME G 114 10 HET CME G 221 10 HET NRQ H 65 23 HET CME H 114 10 HET CME H 221 10 HETNAM NRQ {(4Z)-4-(4-HYDROXYBENZYLIDENE)-2-[3-(METHYLTHIO) HETNAM 2 NRQ PROPANIMIDOYL]-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1- HETNAM 3 NRQ YL}ACETIC ACID HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETSYN NRQ CHROMOPHORE (MET-TYR-GLY) FORMUL 2 NRQ 4(C16 H17 N3 O4 S) FORMUL 2 CME 8(C5 H11 N O3 S2) FORMUL 9 HOH *917(H2 O) HELIX 1 1 ALA L 54 CYS L 62 5 9 HELIX 2 2 PHE A 80 PHE A 84 5 5 HELIX 3 3 PRO A 183 LEU A 187 5 5 HELIX 4 4 ALA M 54 CYS M 62 5 9 HELIX 5 5 PHE B 80 PHE B 84 5 5 HELIX 6 6 PRO B 183 LEU B 187 5 5 HELIX 7 7 ALA R 54 CYS R 62 5 9 HELIX 8 8 PHE G 80 PHE G 84 5 5 HELIX 9 9 PRO G 183 LEU G 187 5 5 HELIX 10 10 ALA S 54 CYS S 62 5 9 HELIX 11 11 PHE H 80 PHE H 84 5 5 HELIX 12 12 PRO H 165 GLY H 167 5 3 HELIX 13 13 PRO H 183 LEU H 187 5 5 SHEET 1 A13 LYS A 71 TYR A 72 0 SHEET 2 A13 HIS A 209 ARG A 219 1 O ALA A 218 N LYS A 71 SHEET 3 A13 HIS A 193 GLN A 205 -1 N PHE A 194 O ARG A 219 SHEET 4 A13 GLY A 143 VAL A 150 -1 N GLY A 143 O HIS A 197 SHEET 5 A13 VAL A 153 CYS A 164 -1 O GLN A 157 N ILE A 146 SHEET 6 A13 ARG A 168 SER A 180 -1 O TYR A 178 N LEU A 154 SHEET 7 A13 PHE A 88 TYR A 96 -1 N THR A 89 O ARG A 179 SHEET 8 A13 PHE A 101 ASP A 111 -1 O THR A 108 N PHE A 88 SHEET 9 A13 CME A 114 ASN A 124 -1 O CME A 114 N ASP A 111 SHEET 10 A13 MET L 9 VAL L 19 1 N ARG L 12 O TYR A 117 SHEET 11 A13 HIS L 22 ASN L 33 -1 O GLY L 32 N MET L 9 SHEET 12 A13 THR L 38 GLU L 47 -1 O LYS L 42 N LYS L 29 SHEET 13 A13 HIS A 209 ARG A 219 -1 O TYR A 210 N ILE L 43 SHEET 1 B13 LYS B 71 TYR B 72 0 SHEET 2 B13 HIS B 209 ARG B 219 1 O ALA B 218 N LYS B 71 SHEET 3 B13 HIS B 193 GLN B 205 -1 N GLU B 200 O TYR B 213 SHEET 4 B13 GLY B 143 VAL B 150 -1 N GLY B 143 O HIS B 197 SHEET 5 B13 VAL B 153 CYS B 164 -1 O GLN B 157 N ILE B 146 SHEET 6 B13 ARG B 168 SER B 180 -1 O TYR B 178 N LEU B 154 SHEET 7 B13 PHE B 88 TYR B 96 -1 N THR B 89 O ARG B 179 SHEET 8 B13 PHE B 101 ASP B 111 -1 O GLN B 106 N TRP B 90 SHEET 9 B13 CME B 114 ASN B 124 -1 O CME B 114 N ASP B 111 SHEET 10 B13 MET M 9 VAL M 19 1 N ARG M 12 O TYR B 117 SHEET 11 B13 HIS M 22 ASN M 33 -1 O CYS M 26 N MET M 15 SHEET 12 B13 THR M 38 GLU M 47 -1 O ASP M 40 N GLU M 31 SHEET 13 B13 HIS B 209 ARG B 219 -1 O TYR B 210 N ILE M 43 SHEET 1 C13 LYS G 71 TYR G 72 0 SHEET 2 C13 HIS G 209 ARG G 219 1 O ALA G 218 N LYS G 71 SHEET 3 C13 HIS G 193 GLN G 205 -1 N GLU G 200 O TYR G 213 SHEET 4 C13 GLY G 143 VAL G 150 -1 N GLY G 143 O HIS G 197 SHEET 5 C13 VAL G 153 CYS G 164 -1 O GLN G 157 N ILE G 146 SHEET 6 C13 ARG G 168 SER G 180 -1 O TYR G 178 N LEU G 154 SHEET 7 C13 PHE G 88 TYR G 96 -1 N THR G 89 O ARG G 179 SHEET 8 C13 PHE G 101 ASP G 111 -1 O LEU G 102 N THR G 94 SHEET 9 C13 CME G 114 ASN G 124 -1 O CME G 114 N ASP G 111 SHEET 10 C13 MET R 9 VAL R 19 1 N ARG R 12 O TYR G 117 SHEET 11 C13 HIS R 22 ASN R 33 -1 O CYS R 26 N MET R 15 SHEET 12 C13 THR R 38 GLU R 47 -1 O LYS R 42 N LYS R 29 SHEET 13 C13 HIS G 209 ARG G 219 -1 O TYR G 210 N ILE R 43 SHEET 1 D13 LYS H 71 TYR H 72 0 SHEET 2 D13 HIS H 209 ARG H 219 1 O ALA H 218 N LYS H 71 SHEET 3 D13 HIS H 193 GLN H 205 -1 N GLU H 200 O TYR H 213 SHEET 4 D13 GLY H 143 VAL H 150 -1 N GLY H 143 O HIS H 197 SHEET 5 D13 VAL H 153 CYS H 164 -1 O GLN H 157 N ILE H 146 SHEET 6 D13 ARG H 168 SER H 180 -1 O TYR H 178 N LEU H 154 SHEET 7 D13 PHE H 88 TYR H 96 -1 N THR H 89 O ARG H 179 SHEET 8 D13 PHE H 101 ASP H 111 -1 O GLN H 106 N TRP H 90 SHEET 9 D13 CME H 114 ASN H 124 -1 O CME H 114 N ASP H 111 SHEET 10 D13 MET S 9 VAL S 19 1 N THR S 18 O GLY H 123 SHEET 11 D13 HIS S 22 ASN S 33 -1 O CYS S 26 N MET S 15 SHEET 12 D13 THR S 38 GLU S 47 -1 O GLU S 44 N THR S 27 SHEET 13 D13 HIS H 209 ARG H 219 -1 O TYR H 210 N ILE S 43 SSBOND 1 CYS A 144 CYS B 144 1555 1555 2.26 SSBOND 2 CYS G 144 CYS H 144 1555 1555 2.24 LINK C3 NRQ A 65 N SER A 66 1555 1555 1.32 LINK C ASP A 113 N CME A 114 1555 1555 1.33 LINK C CME A 114 N LEU A 115 1555 1555 1.33 LINK C TYR A 220 N CME A 221 1555 1555 1.33 LINK C CME A 221 N ASP A 222 1555 1555 1.33 LINK C3 NRQ B 65 N SER B 66 1555 1555 1.32 LINK C ASP B 113 N CME B 114 1555 1555 1.33 LINK C CME B 114 N LEU B 115 1555 1555 1.33 LINK C TYR B 220 N CME B 221 1555 1555 1.33 LINK C CME B 221 N ASP B 222 1555 1555 1.33 LINK C3 NRQ G 65 N SER G 66 1555 1555 1.32 LINK C ASP G 113 N CME G 114 1555 1555 1.33 LINK C CME G 114 N LEU G 115 1555 1555 1.33 LINK C TYR G 220 N CME G 221 1555 1555 1.33 LINK C CME G 221 N ASP G 222 1555 1555 1.33 LINK C3 NRQ H 65 N SER H 66 1555 1555 1.33 LINK C AASP H 113 N CME H 114 1555 1555 1.33 LINK C BASP H 113 N CME H 114 1555 1555 1.33 LINK C CME H 114 N LEU H 115 1555 1555 1.33 LINK C TYR H 220 N CME H 221 1555 1555 1.33 LINK C CME H 221 N ASP H 222 1555 1555 1.33 CISPEP 1 GLY L 49 PRO L 50 0 -5.27 CISPEP 2 PHE A 84 PRO A 85 0 8.85 CISPEP 3 GLY M 49 PRO M 50 0 -1.75 CISPEP 4 PHE B 84 PRO B 85 0 7.48 CISPEP 5 GLY R 49 PRO R 50 0 -5.19 CISPEP 6 PHE G 84 PRO G 85 0 8.94 CISPEP 7 GLY S 49 PRO S 50 0 -1.97 CISPEP 8 PHE H 84 PRO H 85 0 7.07 CRYST1 98.418 98.360 242.626 90.00 90.00 90.00 C 2 2 21 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010161 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010167 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004122 0.00000